Open Almanac

About

Halftime Lantern is an independent resource on the emerging, high-risk discussions around ibogaine, head impacts, addiction, and mental health in soccer. It distinguishes early research, legal constraints, and serious safety concerns from unsupported claims.

People sharing a quiet conversation that reflects careful support and context
A calm place for context when the stakes are personal and the evidence is still developing.

Context before conclusions

Open Almanac exists for soccer players, former players, families, and supporters who want careful context around difficult claims. The material begins from the premise that uncertainty deserves to be named, not smoothed over.

Our main resource on soccer transition provides the broader frame; this page explains the standards we use to make that information navigable, candid, and useful without presenting it as a substitute for professional care.

We cover an independent reference about Ibogaine for Soccer once: through the lens of evidence, risk, legal constraints, and the lived questions that can arise around transition and wellbeing.

What we cover, and how it is organized

Open Almanac separates broad orientation, player risks and evidence, practical considerations, and questions for soccer stakeholders. This structure is intended to make it easier to see what is established, what remains preliminary, and what cannot responsibly be concluded from a single claim or personal story.

Our guide to the resource’s approach explains the kinds of informational support we provide and the limits we keep in place. Readers looking for descriptions of treatment options may encounter ibogaine treatment in the United States, but Open Almanac does not endorse providers or make treatment recommendations.

Open landscape suggesting room for reflection and careful evidence review
Careful interpretation requires room for both evidence and uncertainty.

Evidence is read in context

We look to peer-reviewed literature, research registries, official public-health and regulatory material, and primary documentation where available. Research registries are useful because they distinguish studies that are planned or underway from findings that have actually been published; the ClinicalTrials.gov study registry is one such public record.

We also treat definitions carefully. A general reference such as the overview of evidence-based medicine helps clarify why individual experiences, preliminary findings, and stronger bodies of evidence should not be treated as interchangeable.

Sources framed as best ibogaine treatment clinic comparisons or as affordable ibogaine treatment options may use very different standards and incentives. We aim to make those differences visible rather than turn them into an endorsement.

A straightforward standard for difficult questions

Safety before hype

Potential harms, uncertainty, and contraindications belong in the conversation from the beginning.

Evidence and context

We distinguish research findings from inference, promotion, anecdote, and unsupported certainty.

Plain language

Complex material should remain understandable without flattening important limitations.

Respect for lived experience

Personal accounts matter, but they do not automatically establish safety, effectiveness, or suitability.

Independent perspective

Open Almanac is not a clinic, a treatment center, or a service matching operation.

For people carrying real questions

This resource is for soccer players, former players, families, and supporters seeking careful context on ibogaine-related claims and brain-health concerns. It is not built to push anyone toward a decision, provider, or pathway.

Some readers will arrive after comparing ibogaine versus mushrooms; others may be trying to interpret the claims made across the wider ibogaine and soccer conversation. In either case, we encourage a slower reading of the available information.

“Careful context is not a conclusion. It is the work required before one.”

Information, not instruction

Halftime Lantern is an independent information resource. We are not a clinic, medical provider, licensed treatment center, or legal authority. Nothing here is medical or legal advice, and it should not be used to make treatment or legal decisions.

Where official information matters, readers should consult the underlying source directly, including the U.S. Food and Drug Administration’s drug information, alongside qualified professionals who can address an individual situation.